Torrent, Zydus, EQT set to make the cut for $3 bn JB Chemicals buyout

Torrent Pharma and Zydus Lifesciences are vying to acquire JB Chemicals and Pharmaceuticals, with both firms shortlisted by KKR, the current owner. Torrent has started discussions with banks for financing, while private equity firm EQT is also expected to participate. Dr. Reddy’s Laboratories has shown interest but has yet to submit an offer.